Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against CVS Health Corporation
2019 AUG 28 (NewsRx) -- By a
The Private Securities Litigation Reform Act of 1995 permits any former Aetna shareholders who acquired CVS shares in exchange for their Aetna shares in connection with CVS’s acquisition of Aetna to seek appointment as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from today. If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel,
The complaint charges CVS and certain of CVS’s and Aetna’s officers and directors with violations of the Securities Act of 1933. CVS provides retail pharmacy and pharmacy benefit manager services nationwide. On
In connection with the acquisition of Aetna (the “Acquisition”), defendants filed with the
In
After the Aetna shareholders had approved the Acquisition, in
On
In late
Plaintiff seeks to recover damages on behalf of any former Aetna shareholders who acquired CVS shares in exchange for their Aetna shares in connection with the Acquisition (the “Class”). The plaintiff is represented by Robbins Geller, which has extensive experience in prosecuting investor class actions including actions involving financial fraud.
(Our reports deliver fact-based news of research and discoveries from around the world.)
Weather Winning Streak Into Labor Day – Why We Probably Shouldn’t Nuke Hurricanes
V– VAMC Togus Maine Wheelchair Transportation
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News